Position in ROIV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$20,844
New position
Shares Held
589
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#395
of 489 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026SMA Capital LLC holds $374,384 across 28 Biotechnology names. ROIV ranks #3 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
282 | $21,003 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
112 | $20,975 | |
| 3 | ROIV |
Roivant Sciences Ltd.
This page
|
589 | $20,844 | |
| 4 | MRNA |
Moderna, Inc.
|
297 | $20,798 | |
| 5 | CYTK |
Cytokinetics Inc
|
244 | $20,786 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
260 | $20,615 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
84 | $20,560 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
55 | $20,441 |
All Filings in ROIV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,844 | 589 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||